Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
iSpecimen ( (ISPC) ) has issued an update.
On June 4, 2025, iSpecimen Inc. received a notification from Nasdaq indicating non-compliance with the minimum stockholders’ equity requirement of $2.5 million for continued listing on the Nasdaq Capital Market, as their equity was reported at $1,668,513. The company has 45 days to submit a compliance plan, and if accepted, may receive an extension of up to 180 days to meet the listing criteria, although there is no guarantee of acceptance or compliance.
Spark’s Take on ISPC Stock
According to Spark, TipRanks’ AI Analyst, ISPC is a Neutral.
The overall stock score of 40.4 reflects significant financial challenges, poor valuation metrics, and bearish technical trends. The financial performance is a major concern with declining revenues and persistent losses. The technical analysis suggests a bearish trend, and the negative P/E ratio indicates a lack of profitability. Improvements are necessary for a positive outlook.
To see Spark’s full report on ISPC stock, click here.
More about iSpecimen
Average Trading Volume: 77,636
Technical Sentiment Signal: Sell
Current Market Cap: $3.18M
For a thorough assessment of ISPC stock, go to TipRanks’ Stock Analysis page.